SCHEDULE: FMR LLC Reports 10.2% Stake in Kestra Medical Technologies
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson have disclosed an aggregate beneficial ownership of 10.2% of Kestra Medical Technologies Inc.'s common stock as of September 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 5,225,988 shares of Kestra Medical Technologies Inc. common stock.
- This ownership represents 10.2% of the total outstanding common stock of Kestra Medical Technologies Inc.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- FMR LLC holds sole voting power over 5,225,753 shares and sole dispositive power over 5,225,988 shares.
- Abigail P. Johnson holds sole dispositive power over 5,225,988 shares.
- The report is an Amendment No. 1 to a Schedule 13G filing.
- Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, are identified as entities beneficially owning shares, with Fidelity Management & Research Company LLC beneficially owning 5% or greater of the outstanding shares.
Sentiment
Score: 7
Explanation: The disclosure of a significant institutional stake by a reputable firm like FMR LLC is generally viewed positively, indicating confidence in the company's prospects, even if it's a passive investment.
Positives
- Significant institutional investment from FMR LLC, a major asset manager, indicates confidence in Kestra Medical Technologies Inc.'s prospects.
- The holding represents a substantial 10.2% of the company's common stock, signaling a notable commitment.
- The acquisition is stated to be in the ordinary course of business, suggesting a long-term investment perspective rather than an activist or control-seeking stance.
Negatives
- No explicit negative information is contained within this beneficial ownership report.
Risks
- The filing explicitly states that the securities were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating potential control-related risks for Kestra Medical Technologies Inc.
Future Outlook
The filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Kestra Medical Technologies Inc.'s future performance or strategic direction.
Management Comments
- The filing is a disclosure by FMR LLC and Abigail P. Johnson, not Kestra Medical Technologies Inc. management, and therefore does not contain direct quotes or paraphrased statements from Kestra's management.
Industry Context
The medical technology sector often attracts significant institutional investment due to its potential for innovation, growth, and stable demand. A substantial stake by a major asset manager like FMR LLC in Kestra Medical Technologies Inc. suggests a positive long-term view on the company's position within this industry, potentially driven by its product pipeline, market penetration, or overall sector trends.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- The filing does not disclose any litigation or regulatory matters concerning Kestra Medical Technologies Inc.
Related Party Transactions
- The filing does not disclose any related party dealings involving Kestra Medical Technologies Inc.
Stakeholder Impact
- Shareholders: Increased institutional ownership may enhance market confidence and potentially stabilize the stock price.
- Company Management: A significant institutional investor may bring increased scrutiny or engagement, though the filing states the investment is not for control.
Next Steps
- The filing does not mention any specific future actions, events, or milestones for Kestra Medical Technologies Inc. related to this ownership disclosure.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | FMR LLC filed Exhibit 24 to Schedule 13G (accession number: -23-000003). |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | FMR LLC filed Exhibit 24 to Schedule 13G (accession number: -23-000038). |
| 2025-09-30 | Date of event which requires filing of this statement. |
| 2025-10-06 | Date of joint filing agreement and signature date for Schedule 13G. |
Recommendation
holdThe filing indicates a significant, passive institutional investment by FMR LLC, which is generally a positive signal of confidence in Kestra Medical Technologies Inc. However, a Schedule 13G primarily serves as a disclosure of ownership and does not provide sufficient operational or financial details to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' their position and await further financial reports or strategic updates from the company to make more informed decisions, while acknowledging the positive signal from this institutional stake.
Keywords
Kestra Medical Technologies, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock, Medical Technology, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.